Clinical Trials Directory

Trials / Completed

CompletedNCT00826943

Is Levocetirizine Less Sedating Than Cetirizine?

Is Levocetirizine Less Sedating Than Cetirizine? A Randomized, Double-blind, Placebo Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years – 77 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether cetirizine (zyrtec), levocetirizine (xyzal), and placebo differ in the degree of sedation they produce and their relief of allergy symptoms.

Detailed description

Levocetirizine, the R-enantiomer of cetirizine, has been found to be less sedating relative to placebo than was cetirizine in separate trials. We plan to examine whether patients who did not tolerate cetirizine due to sedation are able to tolerate levocetirizine. This study will utilize a randomized, double-blind, placebo controlled trial comparing levocetirizine, cetirizine, and placebo in regards to sedation and allergy symptom scores. Each patient will receive levocetirizine, cetirizine, and placebo in randomized order and thus serve as their own control.

Conditions

Interventions

TypeNameDescription
DRUGCetirizineCetirizine 10 mg tab daily x 7 days
DRUGLevocetirizine5 mg tab daily x 7 days
DRUGPlaceboPlacebo tablet daily x 7 days

Timeline

Start date
2009-01-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2009-01-22
Last updated
2014-02-20
Results posted
2014-02-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00826943. Inclusion in this directory is not an endorsement.